Your browser doesn't support javascript.
loading
Continuity of treatment in ALS: Benefits and challenges of maintaining riluzole over the course of the disease.
Silani, Vincenzo.
Affiliation
  • Silani V; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy; Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milan, Italy.
J Neurol Sci ; 461: 123038, 2024 Jun 15.
Article in En | MEDLINE | ID: mdl-38761668
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroprotective Agents / Riluzole / Amyotrophic Lateral Sclerosis Limits: Female / Humans / Male / Middle aged Language: En Journal: J Neurol Sci / J. neurol. sci / Journal of the neurological sciences Year: 2024 Document type: Article Affiliation country: Italia Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroprotective Agents / Riluzole / Amyotrophic Lateral Sclerosis Limits: Female / Humans / Male / Middle aged Language: En Journal: J Neurol Sci / J. neurol. sci / Journal of the neurological sciences Year: 2024 Document type: Article Affiliation country: Italia Country of publication: Países Bajos